MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,410 | -76.0% | 16,200 | -67.6% | 0.00% | -80.0% |
| Q2 2023 | $543,000 | -45.3% | 50,000 | -65.2% | 0.01% | -50.0% |
| Q1 2023 | $992,068 | +127.6% | 143,778 | +31.3% | 0.02% | +233.3% |
| Q4 2022 | $435,898 | -59.4% | 109,522 | -4.8% | 0.01% | -53.8% |
| Q1 2022 | $1,074,000 | +6.9% | 115,000 | +39.8% | 0.01% | -43.5% |
| Q4 2020 | $1,005,000 | -90.7% | 82,289 | -90.2% | 0.02% | -90.9% |
| Q3 2020 | $10,764,000 | – | 837,825 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |